Literature DB >> 26936667

Confronting Ebola as a Sexually Transmitted Infection.

William A Fischer1, David A Wohl2.   

Abstract

The unprecedented Ebola outbreak that devastated West Africa evolved within months from a regional outbreak to a global public health emergency. While the rate of confirmed cases declined dramatically, sporadic clusters of Ebola virus disease (EVD) continue well beyond the double incubation period of 42 days used to declare a nation Ebola-free. At the same time, evidence that the virus persists in genital fluids and can be sexually transmitted, along with the potential for lingering virus in other body compartments to permit recrudescence of EVD, has shaken our thinking of what it takes to achieve lasting control of an Ebola epidemic. A comprehensive response to the threat of persistence and sexual transmission of Ebola is required and should build on accessible longitudinal medical care of survivors and accurate genital fluid testing for Ebola. Control of this and future Ebola outbreaks will depend on our ability to recognize and respond to this persistence of the virus in those who survive.
© The Author 2016. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail journals.permissions@oup.com.

Entities:  

Keywords:  Ebola virus disease; emerging infectious diseases; sexually transmitted infection; viral compartmentalization; viral shedding in semen and vaginal fluid

Mesh:

Year:  2016        PMID: 26936667      PMCID: PMC4845792          DOI: 10.1093/cid/ciw123

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  11 in total

1.  Molecular Evidence of Sexual Transmission of Ebola Virus.

Authors:  Suzanne E Mate; Jeffrey R Kugelman; Tolbert G Nyenswah; Jason T Ladner; Michael R Wiley; Thierry Cordier-Lassalle; Athalia Christie; Gary P Schroth; Stephen M Gross; Gloria J Davies-Wayne; Shivam A Shinde; Ratnesh Murugan; Sonpon B Sieh; Moses Badio; Lawrence Fakoli; Fahn Taweh; Emmie de Wit; Neeltje van Doremalen; Vincent J Munster; James Pettitt; Karla Prieto; Ben W Humrighouse; Ute Ströher; Joseph W DiClaro; Lisa E Hensley; Randal J Schoepp; David Safronetz; Joseph Fair; Jens H Kuhn; David J Blackley; A Scott Laney; Desmond E Williams; Terrence Lo; Alex Gasasira; Stuart T Nichol; Pierre Formenty; Francis N Kateh; Kevin M De Cock; Fatorma Bolay; Mariano Sanchez-Lockhart; Gustavo Palacios
Journal:  N Engl J Med       Date:  2015-10-14       Impact factor: 91.245

2.  Unexpected Ebola virus in a tertiary setting: clinical and epidemiologic aspects.

Authors:  G A Richards; S Murphy; R Jobson; M Mer; C Zinman; R Taylor; R Swanepoel; A Duse; G Sharp; I C De La Rey; C Kassianides
Journal:  Crit Care Med       Date:  2000-01       Impact factor: 7.598

3.  Persistence of Ebola Virus in Ocular Fluid during Convalescence.

Authors:  Jay B Varkey; Jessica G Shantha; Ian Crozier; Colleen S Kraft; G Marshall Lyon; Aneesh K Mehta; Gokul Kumar; Justine R Smith; Markus H Kainulainen; Shannon Whitmer; Ute Ströher; Timothy M Uyeki; Bruce S Ribner; Steven Yeh
Journal:  N Engl J Med       Date:  2015-05-07       Impact factor: 91.245

4.  Persistence and genetic stability of Ebola virus during the outbreak in Kikwit, Democratic Republic of the Congo, 1995.

Authors:  L L Rodriguez; A De Roo; Y Guimard; S G Trappier; A Sanchez; D Bressler; A J Williams; A K Rowe; J Bertolli; A S Khan; T G Ksiazek; C J Peters; S T Nichol
Journal:  J Infect Dis       Date:  1999-02       Impact factor: 5.226

5.  Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission de Lutte contre les Epidémies à Kikwit.

Authors:  A K Rowe; J Bertolli; A S Khan; R Mukunu; J J Muyembe-Tamfum; D Bressler; A J Williams; C J Peters; L Rodriguez; H Feldmann; S T Nichol; P E Rollin; T G Ksiazek
Journal:  J Infect Dis       Date:  1999-02       Impact factor: 5.226

6.  Assessment of the risk of Ebola virus transmission from bodily fluids and fomites.

Authors:  Daniel G Bausch; Jonathan S Towner; Scott F Dowell; Felix Kaducu; Matthew Lukwiya; Anthony Sanchez; Stuart T Nichol; Thomas G Ksiazek; Pierre E Rollin
Journal:  J Infect Dis       Date:  2007-11-15       Impact factor: 5.226

7.  Ebola RNA Persistence in Semen of Ebola Virus Disease Survivors - Final Report.

Authors:  Gibrilla F Deen; Nathalie Broutet; Wenbo Xu; Barbara Knust; Foday R Sesay; Suzanna L R McDonald; Elizabeth Ervin; Jaclyn E Marrinan; Philippe Gaillard; Ndema Habib; Hongtu Liu; William Liu; Anna E Thorson; Francis Yamba; Thomas A Massaquoi; Faustin James; Archchun Ariyarajah; Christine Ross; Kyle Bernstein; Antoine Coursier; John Klena; Marylin Carino; Alie H Wurie; Yong Zhang; Marion S Dumbuya; Neetu Abad; Baimba Idriss; Teodora Wi; Sarah D Bennett; Tina Davies; Faiqa K Ebrahim; Elissa Meites; Dhamari Naidoo; Samuel J Smith; Patricia Ongpin; Tasneem Malik; Anshu Banerjee; Bobbie R Erickson; Yongjian Liu; Yang Liu; Ke Xu; Aaron Brault; Kara N Durski; Jörn Winter; Tara Sealy; Stuart T Nichol; Margaret Lamunu; James Bangura; Sihem Landoulsi; Amara Jambai; Oliver Morgan; Guizhen Wu; Mifang Liang; Qiudong Su; Yu Lan; Yanzhe Hao; Pierre Formenty; Ute Ströher; Foday Sahr
Journal:  N Engl J Med       Date:  2015-10-14       Impact factor: 91.245

8.  Possible sexual transmission of Ebola virus - Liberia, 2015.

Authors:  Athalia Christie; Gloria J Davies-Wayne; Thierry Cordier-Lassalle; Thierry Cordier-Lasalle; David J Blackley; A Scott Laney; Desmond E Williams; Shivam A Shinde; Moses Badio; Terrence Lo; Suzanne E Mate; Jason T Ladner; Michael R Wiley; Jeffrey R Kugelman; Gustavo Palacios; Michael R Holbrook; Krisztina B Janosko; Emmie de Wit; Neeltje van Doremalen; Vincent J Munster; James Pettitt; Randal J Schoepp; Leen Verhenne; Iro Evlampidou; Karsor K Kollie; Sonpon B Sieh; Alex Gasasira; Fatorma Bolay; Francis N Kateh; Tolbert G Nyenswah; Kevin M De Cock
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-05-08       Impact factor: 17.586

9.  Ebola Virus Disease Complicated by Late-Onset Encephalitis and Polyarthritis, Sierra Leone.

Authors:  Patrick Howlett; Colin Brown; Trina Helderman; Tim Brooks; Durodamil Lisk; Gibrilla Deen; Marylou Solbrig; Marta Lado
Journal:  Emerg Infect Dis       Date:  2016-01       Impact factor: 6.883

Review 10.  Addressing Ebola-related stigma: lessons learned from HIV/AIDS.

Authors:  Mariam Davtyan; Brandon Brown; Morenike Oluwatoyin Folayan
Journal:  Glob Health Action       Date:  2014-11-07       Impact factor: 2.640

View more
  15 in total

1.  SARS-CoV-2 (COVID-19): Beginning to Understand a New Virus.

Authors:  Giau Van Vo; Eva Bagyinszky; Yoon Soo Park; John Hulme; Seong Soo A An
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  External quality assessment study for ebolavirus PCR-diagnostic promotes international preparedness during the 2014 - 2016 Ebola outbreak in West Africa.

Authors:  Heinz Ellerbrok; Sonja Jacobsen; Pranav Patel; Toni Rieger; Markus Eickmann; Stephan Becker; Stephan Günther; Dhamari Naidoo; Livia Schrick; Kathrin Keeren; Angelina Targosz; Anette Teichmann; Pierre Formenty; Matthias Niedrig
Journal:  PLoS Negl Trop Dis       Date:  2017-05-01

3.  Development of risk reduction behavioral counseling for Ebola virus disease survivors enrolled in the Sierra Leone Ebola Virus Persistence Study, 2015-2016.

Authors:  Neetu Abad; Tasneem Malik; Archchun Ariyarajah; Patricia Ongpin; Matthew Hogben; Suzanna L R McDonald; Jaclyn Marrinan; Thomas Massaquoi; Anna Thorson; Elizabeth Ervin; Kyle Bernstein; Christine Ross; William J Liu; Karen Kroeger; Kara N Durski; Nathalie Broutet; Barbara Knust; Gibrilla F Deen
Journal:  PLoS Negl Trop Dis       Date:  2017-09-11

4.  Ebola Virus Ribonucleic Acid Detection in Semen More Than Two Years After Resolution of Acute Ebola Virus Infection.

Authors:  William A Fischer; Jerry Brown; David Alain Wohl; Amy James Loftis; Sam Tozay; Edwina Reeves; Korto Pewu; Galapaki Gorvego; Saturday Quellie; Coleen K Cunningham; Carson Merenbloom; Sonia Napravnik; Karine Dube; David Adjasoo; Erin Jones; Korlia Bonarwolo; David Hoover
Journal:  Open Forum Infect Dis       Date:  2017-07-22       Impact factor: 3.835

5.  Better drugs for Lyme disease: focus on the spirochete.

Authors:  Raphael B Stricker; Marianne J Middelveen
Journal:  Infect Drug Resist       Date:  2018-09-07       Impact factor: 4.003

6.  Potential Risk of Virus Carryover by Fabrics of Personal Protective Gowns.

Authors:  Iyoko Katoh; Fuminori Tanabe; Hirotake Kasai; Kohji Moriishi; Noriko Shimasaki; Katsuaki Shinohara; Yukiko Uchida; Tomoko Koshiba; Soichi Arakawa; Michiko Morimoto
Journal:  Front Public Health       Date:  2019-05-22

7.  Detection of severe acute respiratory syndrome corona virus 2 in cervico-vaginal secretion of COVID-19-affected female: A prospective observational study from India.

Authors:  Mukta Agarwal; Swmkwr Basumatary; Divendu Bhusan; Binod Kumar Pati
Journal:  SAGE Open Med       Date:  2021-06-03

8.  Pregnancy, Labor, and Delivery after Ebola Virus Disease and Implications for Infection Control in Obstetric Services, United States.

Authors:  Amanda Kamali; Denise J Jamieson; Julius Kpaduwa; Sarah Schrier; Moon Kim; Nicole M Green; Ute Ströher; Atis Muehlenbachs; Michael Bell; Pierre E Rollin; Laurene Mascola
Journal:  Emerg Infect Dis       Date:  2016-07-15       Impact factor: 6.883

9.  Use of the Filovirus Animal Non-Clinical Group (FANG) Ebola virus immuno-assay requires fewer study participants to power a study than the Alpha Diagnostic International assay.

Authors:  James Logue; Kaylie Tuznik; Dean Follmann; Greg Grandits; Jonathan Marchand; Cavan Reilly; Yeya Dit Sadio Sarro; James Pettitt; Eric J Stavale; Mosoka Fallah; Gene G Olinger; Fatorma K Bolay; Lisa E Hensley
Journal:  J Virol Methods       Date:  2018-02-23       Impact factor: 2.014

Review 10.  [Epidemic and emerging prone-infectious diseases: Lessons learned and ways forward].

Authors:  Denis Malvy; Bernard-Alex Gaüzère; René Migliani
Journal:  Presse Med       Date:  2019-11-26       Impact factor: 1.228

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.